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Protocol and Cost-Effective Screening
JOHN P . BOURKE. MB, MRCP, DAVID A . B . RICHARDS, MD, FRACP, FACC,
DAVID L . ROSS, FRACP, FACC, ELIZABETH M . WALLACE, BSc,
MARK A . McGUIRE, MB, BS, BMEDSc, FRACP, JOHN B . UTHER, MD, FRACP
West stead, Nov South Wakes . Australia
Of 3,286 consecutive patients treated for acute myocardial infarc-
tion, electrophysiologic testing was performed in 1,209 survivors
(37%) free of significant complications at the time of hospital
discharge to determine their risk of spontaneous ventricular
tachyarrhythmias during follow-up . Sustained monomorphic vets
tricular tachycardia was inducible by programmed electrical
stimulation in 75 (6 .2%). Antiarrhylhmic therapy was not rou-
tinely prescribed regardless of the test results .
During the 1st year of follow-up, 14 infarct survivors (19%)
with inducible ventricular tachycardia experienced spontaneous
ventricular tachycardia or fibrillation in the absence of new
ischemia compared with 34 (2.9%) of those without inducible
ventricular taehyenrdia (p < 0 .0005). During the extended
follow-up period (median 28 months) of those with inducible
The occurrence of ventricular lachyarrhythmias after hospi-
tal discharge is the major cause of death in the 1st year after
acute myocardial infarction (1-3)
. These arrhythmias are due
to reentry in the border zone between chronic scar and
normal myocardium in the absence of fresh ischemia and
often occur in otherwise healthy and asymplomatic patients
(4-7) . Although tests designed to quantify the degree of left
ventricular dysfunction or residual ischemia in infarct survi-
vors do have prognostic value, they do not identify patients
prone to arrhythmic death .
Although the single best test for the prediction of late
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ventricular tacbycardia, 19 (25%) had a spontaneous electrical
vent ; 37% of these first events were fatal . These results suggest
that the most cost-effective strategy for predicting arrhythmia will
be obtained by restricting electrophysiotogic testing to infarct
survivors wham left ventricular ejection fraction is <40% and
using a stimulation protocol containing four extraslimuli .
Electrophysiologic testing is the single best predictor of spon-
taneous ventricular tachyarrhythmias during follow-up in infarct
survivors . The majority (94%) with a negative test benefit from
the more reliable reassurance that all Is well, whereas the 25%
risk of electrical events in those with inducible ventricular tachy .
eardia justifies a prospective trial of effective prophylactic anti .
arrhythmic interventions .
(J Am Coll Cardiol 1991 ;18:780-8)
ventricular tachyarrhythmias after infarction is programmed
electrical stimulation (8.9), most centers have been reluctant
to use this method to screen infarct survivors for evidence of
ventricular electrical instability . This is partly explained by
conflicting results published (10-15) on the use of pro-
grammed electrical stimulation for this purpose . However,
many clinicians are also wary of using provocative invasive
testing and are apprehensive about the safety of such an
approach . Furthermore, only a small proportion of patients
in the studies published (10-15) were found to be at risk,
suggesting that stratification on the basis of other risk factors
could be used to diminish the proportion of infarct survivors
requiring electrophysiotogic testing .
This study examined the results of 9 years of routine
electrophysiotogic testing in a large group of survivors of
myocardial infarction who had not experienced spontaneous
ventricular tachycardia or fibrillation after the 1st 48 h after
infarction. A second aim was to examine ways of improving
the costlbenefit ratio of using electrophysiologic testing to
assess late arrhythmic risk in infarct survivors at the time of
hospital discharge .
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Methods
Since the January 1980 approval by the Research and
Human Ethics Review Committee at Wnstmead Hospital.
programmed electrical stimulation has been offered routinely
to all survivors of myocardial infarction . The present pro-
spective study was designed to determine the ability of
electrophysiologic testing to predict the occurrence of sud-
den death and spontaneous ventricular tachycardia and
fibrillation during follow-up in infarct survivors
.
Selection criteria and protocol for electrophysiologic test-
ing . Informed written consent for invasive electrophysio-
logic testing was sought from 1,936 of 3,286 patients who had
sustained an acute myocardial infarction by standard symp-
tom, electrocardiographic (EC(i) and cardiac enzyme crite-
ria. Patients were excluded from electrophysiologic study if
they had : 1) experienced early recurrence of angina requiring
therapy with a beta-adrenergic blocker, calcium channel
antagonist or coronary artery bypass grafting : 2) experi-
enced spontaneous ventricular tachycardia or fibrillation
after the Ist 48 h after infarction (ventricular tachycardia or
fibrillation within the 1st 48 h was considered to be related to
acute ischemia and was not a reason for exclusion) ; 31
clinical heart failure not controlled by treatment with furo-
semide, 40 mg/day; and 4) had significant noncardiac dis-
ease . Electrophysiologic testing was performed between
days 6 and 28 after infarction (usually at days 7 to 10 just
before routine hospital discharge) on the 1 .209 patients who
consented. The study group comprised patients who were
clinically well at the time of electrophysiologic testing . No
study patient had received a beta-adrenergic blocking drug .
digoxin or other antiarrhythmic therapy for 0_7 days before
electrophysiologic testing
.
Electrophysiologic testing was performed with patients in
the postabsorptive state under diazepam sedation and 19c
lignocaine local anesthesia . During the 9-year period of this
data collection, two different stimulation protocols were
used, From January 1980 to December 1986, protocol I was
used, From July 1984 to December 1988, protocol 2 was
used. Both protocols were used in each patient during the
overlapping 2-year period .
Protocol 1 . Stimulation was performed using a Medtronic
5325 programmable stimulator delivering 2-ms rectangular
pulse stimuli . Single and double extrastimuli were applied to
the right ventricular apex initially and subsequently at the
right ventricular outflow tract at twice diastolic threshold .
The stimulation protocol was then repeated at each of these
sites with use of high energy stimulation 120 mA) . Stimuli
were applied after an eight-beat drive train (S, S,) with a
cycle length as near to 600 ms as possible . The first extra-
stimulus (S,) was set initially 300 ms from the eighth drive
beat and then progressively decremented in 10-ms steps to
refractoriness . If the earliest possible extrastimulus failed to
induce ventricular tachycardia, that extrastimulus was de-
livered 10 ms outside the ventricular effective refractory
period and the second extrastimulus added and decremented
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in similar fashion to the first extrastimulus
. Each sequence
was applied once before decrementing to the nest interval
and a 3-s pause was inserted between each drive train . End
points of the study included completion of the protocol and
the induction of sustained ventricular tachycardia, flutter or
fibrillation .
Protocol 2. Programmed electrical stimulation was per-
formed at twice diastolic threshold at the right ventricular
apex with use of only a World Precision Instruments pro-
grammable stimulator . applying rectangular 2-ms pulse stim-
uli . Extrastimuli were applied after an eight-beat drive train
as near as possible to a cycle length of 600 ms
. Drive trains
were separated by 3-s pauses. The initial coupling interval
was 3110 ms and was then decreased in 10-ms steps to
ventricular refractoriness . Each extrastimulus coupling in-
terval was delivered three times before it was decreased to
the next I0-ms step. If the earliest possible extrastimulus
failed to induce ventricular tachycardia
. that extrastimulus
was delivered 10 ms outside the ventricular effective refrac-
tory period and an additional extrasttmulus added . This was
decreased in 10-ms steps in the same manner. Additional
extrastimuli were added in a similar manner until zither
ventricular tachycardia, flutter or fibrillation was induced or
refractoriness of the fourth extrastimulus was reached . For a
2-year period (1985 to 1987), a fifth extrastimulus was added
to protocol 2 as part of the ongoing attempts to derive the
optimal stimulation protocol.
End points at electrophysiologic study . End points of
programmed stimulation included the completion of either
protocol or the induction of ventricular tachycardia . flutter
or fibrillation lasting >10 s . Induced arrhythmias were
terminated by either overdrive pacing or direct current
cardioversion . On the basis of previous work from this unit
(15)- only ventricular tachycardia with a cycle length
0_230 ms and lasting >10 s was taken as an abnormal result
.
Separate analysis at this hospital has established that the
induction of ventricular fibrillation, polymorphic ventricular
tachycardia or monomorphic ventricular tachycardia with a
cycle length <230 ms is not associated with a greater
incidence of spontaneous ventricular tachyarrhythmias dur-
ing follow-up than that observed in patients with no induc-
ible arrhythmias . Between January 1984 and December
1985, the value of prophylactic empiric antiarrhythmic drug
therapy in patients who had ventricular tachycardia or
fibrillation induced by these studies was evaluated in a
randomized controlled study
. The results of that study 1161
have been reported in detail . Prophylactic antiarrhythmic
drug therapy was not prescribed re1ardless of the result of
the electrophysiologic study .
Follow-up and end points of the study
. Follow-up was by
telephone contact with patients, their immediate relatives,
their medical attendants or a combination of these at
3-month intervals
. For the purpose of this study, only
documented spontaneous ventricular tachycardia, ventricu-
lar fibrillation and witnessed instantaneous death iII the
absence of symptoms of ischemia were considered arrhyth-
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mic end points . Patients were withdrawn from follow-up if
they died from any cause or had a reinfaretion. Unless one of
these end points had been met, each patient was followed up
for >_ t year from the date of the index infarction . In patients
with inducible ventricular tachycardia, the follow-up period
was extended to December 31, 1989 to allow maximal
opportunity for spontaneous arrhythmic events to occur .
Assessments during initial admission . In addition to re-
cording age, gender and history of previous myocardial
infarction for all patients, peak creatine kinase levels and
radionuclide left ventricular ejection fraction were measured
when possible at the time of hospital discharge . Ejection
fraction was measured by technetium-99m gated blood pool
imaging in the left anterior oblique view, The normal range
of left ventricular ejection fraction at this hospital is 50% to
75%. On the basis of previous work (9,17,18) . a cutoff value
for ejection fraction associated with a poorer prognosis was
set arbitrarily at 40% .
Statistical analysis
. Unless otherwise stated, all values
are quoted as mean values ± I SD . Comparisons between
groups were made using unpaired Student's I test and
chi-square analysis where appropriate . Fisher's exact test
and Yates' corrected chi-square test were used for small
number comparisons. Odds ratios relating to results were
calculated where appropriate.
Results
Inducible ventricular tachycardia
. In the period from
January 1980 to December 1988, 3,286 patients were treated
for acute myocardial infarction at Westmead Hospital . Of
these, 1,209 infarct survivors (37%) who were considered to
be making an uncomplicated recovery underwent pro-
grammed electrical stimulation by protocol I or 2 to deter-
mine their risk of spontaneous ventricular tachycardia or
fibrillation during follow-up . The remaining 2,077 (63%) did
not undergo testing because of patient or physician refusal
(35 6/,), uncontrolled ischemia or heart failure (33%), age >70
years (29%) or death before day 7 after infarction (3%) .
Sustained monomorphic ventricular lachycardia with a
cycle length 0230 ms was inducible in 75 (6
.2%) of the 1,209
patients. The incidence of inducible ventricular tachycardia
showed considerable variability over time, ranging from 1%
in 1982 when only protocol I was used to 11% in 1985 . Figure
I relates the incidence of inducible ventricular tachycardia in
each year of the study to the number of patients undergoing
postinfarction electrophysiologic testing and the total num-
ber of patients treated for infarction in that year . Electro-
physiologic testing was performed a mean of 11 ± 4 days
after infarction . No fatalities or serious vascular, neurologic
or infective complications occurred as a result of this testing
program and the stimulation protocols were well tolerated by
most patients .
Clinical characteristics (Table 1). Patients with and with-
out inducible ventricular tachycardia were comparable in
age, gender distribution and site of index infarction
. How-
1 .ACC Vo1. 1 8 . No . 3
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Figure t . Annual incidence of inducible ventricular tachycardia in
1,209 survivors of myocardial infarction, in relation to the number of
patients undergoing electrophysiologic testing and the total group of
infarct survivors at Westmead Hospital . EPS = patients undergoing
clectrophysiologic study; MI = patients treated for acute myocar-
dial infarction ; VT = patients with inducible sustained ventricular
tachycardia with a cycle length 0230 ms at electrophysiologic study .
ever, more patients with inducible ventricular tachycardia
had a history of previous infarction . Those with inducible
tachycardia also had a significantly higher peak creatine
kinase level during their index infarction and a significantly
Table 1 . Clinical Characteristics of 1,209 Survivors of Myocardial
Infarction With and Without Inducible Ventricular Tachycardia at
Electrophysiologic Study
Vemricular Tachycardia
Year
CK = cocaine U.- F = remote : LVEF = left vcntricul I, election
fraction : M= male : MI = myocardial infarction : VT = ventricular tachycar-
dia .
Inducible Not Inducible p Value
No . 75
1,134 NS
Age lyr) 57 t 9 54'_ 9 NS
rain
61114 9141220 NS
Previous MI
14(191/1 9118%) 0.003
Current MI
Anteriorllalerul 37 (4990) 489(43%) NS
tererierlpeeserior 34 (46%I 579 (51%) NS
Anterior + interior 4 )5%1
5615%) NS
Other 0 (0%) 10(1%) NS
Peak CK level IIUniterl 2,615 t 1 .989 1,811 s 1,982 0 .012
LVEF 11 discharge (%) 34 ± 14 42
0
14 :0 .00056
JACC Val . I8, No. 3
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Table 2 . Natural History of 75 Survivors of Myocardial Infarction
With Inducible Sustained Ventricular Tachvcardis at
Elemrophysiologic Study Without Prior Spontaneous
Ventricular Tachyarrhythmic,
'Only the first arrhythmic event was counted in each patient'~ at each
follow-up one patient had both spontaneous
VTIVF
and instantaneous death
.
tall deaths except instantaneousdeathc and those a0r oeinfaraiun
. Electrical
event = witnessed instantaneous death or documented sustained ventricular
tachymrdin or fibrillation without n a,h,mia
; instantaneous death =
witnessed instantaneous death in the absent, of new ischemic symptoms;
VF = ventricular fibrillation : VT = ventricular tachycardia.
lower ejection fraction at the time of hospital discharge
compared with values in patients without inducible tachy-
cardia .
Outcome in patients with inducible sustained ventricular
tachycardia (Tables 2 and 3). In the 1st year after the index
infarction, 14 (19%) of the 75 patients with inducible ventric-
ular tachycardia were either witnessed to die instanta-
neously or survived a documented spontaneous episode of
ventricular tachycardia or fibrillation in the absence of new
ischemic symptoms
. When the follow-up period was ex-
tended to December 30, 1989 (median follow-up of 28
months in this group of patients), this figure increased to 19
(25%) . The incidence of reinfarction was 7% in the 1st year .
increasing to 9% during the total follow-up period
. Table 2
summarizes the natural history of infarct survivors with
inducible ventricular tachycardia at the time of hospital
discharge, during the Ist year after infarction and during
extended follow-up
. Table 3 compares the clinical outcome
during the 1st year of follow-up in patients with and without
inducible ventricular tachycardia at electrophysiologic study
at the time of hospital discharge . The differences between
the two groups in incidence of electrical events is highly
significant (p < 0 .00(15 ; odds ratio 7 .2) .
The incidence of a first spontaneous arrhythmic event
during the 1st year of follow-up plotted against the year of
index infarction for all patients who underwent electrophys-
iologic testing is shown in Figure 2 . The variation from a
peak incidence in patients enrolled in 1980 to a nadir in those
enrolled in 1987 and 1988 may be due to the effects of the
increasing use of
thrombolytic agents since 1986 on the
incidence of late arrhythmias in infarct survivors (19)
. The
use of thrombolytic therapy at the time of acute infarction
was not recorded as part of this analysis
.
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Table 3
. Comparison of Clinical Outcome During the First Year of
Follow-Up Among 75 Infarct Survivors With and 1 .134 Without
In017,81e Soslaioed Vernacular Iachycardia at the Time of
Hospit¢d Di,chargc
.Abbrevlauons and definitions as in Table , .
Prescription of antiarrhythmic drug therapy based on
electrtlphysiologic result . As part of a randomized placebo-
controlled study 116) of the value of empiric drug therapy in
preventing spontaneous arrhythmias . 18 124%l
of the 75
patients with inducible ventricular tachycardia were pre-
scribed prophylactic drug therapy for the 1st year of
follow-up (quinidine in 6
. mexiletine in 3, disopyramide in I .
sotalol in 5, mctoprolol in 2
. amiodarone in 1) . In only four
of these
. however, was therapy able to suppress the induc-
tion of ventricular tachycardia at repeat electrophysiologic
study . None of these four experienced a spontaneous ar-
rhythmic event. Of the 14 patients (19%) discharged on
nonsuppressive therapy . I survived a spontaneous episode
of ventricular tachycardia 46 days after infarction despite
quinidine therapy and another was witnessed to die instan-
Figure 2. Annual incidence of first spontaneous arrhythmic event
within 12 months of infarction subdivided by outcome . DIED =
patients witnessed to die instantaneously : SURVIVED - patients
surviving a documented episode of ventricular tachycardia or fibril-
lation,
'EAR OF INDEX INFARCTION
Follow-Up Duralon
I Year
Peeler100
131 c L mm
Reinfarcrion 5179c1 719471
Electrical event" 14 0991 I9 (75H1
SponlarcousVTNF 10(139) 12116",1
InO,ntanenus
Vary
5 (77) 8111 711
Other death 10(1351) 16 121911
After reinfarction 3
(497) 4 0l<)
Other',
7 (917) C (16`£1
Alive 601800) 51 (6897.)
Ventricular Tachecardia
Induclblc
1n = 751
Not lrducih;e
In = 1 .1141 S'alue
Remrornon
51777.1 6045",1 40
Electnca1 e,e1l 1411911)
311(07)
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Tabled . Prediction of .Arrhythmic Events Occurring Within
12
Months of Infarction by
fdeclrophysiologic Testing at the Time of Initial Hospital Discharge : Comparison of Protocols I
and 2 in the Same 324 Patients
'Up
w rcfmotndness or the munh eatrastimums .
tancously 561 days after infarction, having been on quinidine
for the first year of follow-up .
A beta-adrenergic blocking agent prescribed for control
of residual ischernic symptoms or hypertension was taken at
some time during the follow-up period by 28 (37%) of those
with compared with 198 (17%) of those without inducible
ventricular tachycardia at their predischarge electrophysio-
logic test (p < 0 .02) . Beta-blockers were not prescribed for
prognostic indications after infarction during the study pe-
riod .
Differences in value of programmed stimulation using
protocol I versus protocol 2 (Tables 4 to 6) . The overall
clinical value of the 9-year program of routine electrophys-
iologic testing in infarct survivors for prediction of sponta-
neous arrhythmic events within the I st year of follow-up had
a sensitivity of 29%, a specificity of 95%, a predictive value
of a positive test of 19%, a predictive value of a negative test
of 97% and an overall test predictive accuracy of 92% .
However, these pooled results mask important differences
between the two stimulation protocols in their predictive
abilities . Table 4 compares the predictive abilities of each of
the protocols for arrhythmic events within the 1st year of
follow-up in a cohort of 324 patients who were studied by
both protocols at the same electrophysiologic study
. Com-
pared with protocol I, protocol 2 was a significantly more
sensitive predictor of arrhythmic events during the Ist year
of follow-up (odds ratios : protocol I = 5 ; protocol 2 = 10.3) .
Normal results by either protocol allowed patients to be
reassured that their risk of spontaneous arrhythmic events
was negligible . However, the reassurance of a normal test
result when protocol 2 was used was highest (negative
Table 5 . Prediction of Arrhythmic Events Occurring Within 12 Months of Infarction by
Electrophysiologic Testing Using Protocol I : Effect of Varying Stimulation Energy and Stimulation
Site in 995 Patients
High energy = 20 mA catgut slimulotion; low
energy = stimulation at twice diastolic threshold ; RV = right
ventricular; RVOT = right ventricular outflow tract .
tACC
V .I
. In . No, 3
4mmeor1 1)91 s 80 - 11
predictive accuracy 99%) when four extrastimuli were ad-
ministered .
Table 5 summarizes the predictive value of protocol I for
arrhythmic events within the I st year of follow-up by stim-
ulation site and stimulation energy . These data were ob-
tained from the cohort of 995 patients who had postinfarction
electrophysiologic testing with this protocol at any time
during the 9 years of the study . Table 6 summarizes the
predictive value of stimulation protocol 2 by the number of
extrastimuli used in the cohort of 525 patients who were
tested by this protocol . The superiority of protocol 2 is
explained by the quantum leap in test sensitivity resulting
from the use of a third extrastimulus . Even when high energy
stimulation was used at both the right ventricular apex and
outflow tract, the test sensitivity of protocol I never ap-
proached that of protocol 2 . A further increase in the test
sensitivity of protocol 2 was evident with the addition of a
fourth extraslimulus. The use of three or four extrastimuli
resulted to acceptable losses in test specificity of protocol 2
at each stage .
Ventricular ejection fraction as a preseleetor for electro-
physiologic testing (Table 7) . The impact of strategies that
limit electrophysiologic testing to infarct survivors with a
ventricular ejection fraction below certain levels on the
predictive value of prognostic testing for the entire study
group during the 1st year of follow-up is summarized in
Table 7 . This analysis is based on a subgroup of 423 patients
who had both ejection fraction measured and programmed
stimulation using protocol 2 to refractoriness of the fourth
extraslimulus performed around the time of hospital dis-
charge. The proportion of infarct survivors requiring etec-
SlimulalionSite aidEnergy
Sensitivity Specificity
113) IIt
Predictive Value
el Positive
Test Result
14)
Predictive Value
of Negative
Test Result
()3)
Predicliv^
Accuracy
(90)
RV Ape.,11- energy 12 98 30 95 94
RV
Ape.vlms + high energy I7 98 33 95 94
RV Ape, I RVOT/low energy 19 99 30 96 93
RV Apev 4 RVOTIlnw a high energy 25 97 29 96 93
Sensitivity
ITTI
Specificity
(7r1
Predictive Value J
Positive Test Result
171
Redictive Value of
Negative Test Result
(%)
Predictive
Accuracy
t%)
Protocol I 23 94
I4 97 91
Protocol 46 92
20
98
90
2 ACC
Vul
. Ix
. No- 1
Suplc ln hor ],,I .,-a
Table 6 . Prediction of Arrhythmic Events Occurring IN, hm i' Slooh, of inf,nd nn he F.Ieclroph, iolu_•l e lb,img l:-.inc Pml0cul
imp--cf he Number of Esira,GmuIi Use{t for Pr-,:mimed Stimulatlov I'n,ems
trophysiologic testing and the proportion of positive teas as
a function of total electrophysiologic tests performed when
such a strategy is used are also shown .
Prediction of arrhythmic events within the tot ye
.:r of
follow-up using an ejection fraction of .4 0rr alone is
sun-
live
(73%) . but the predictive value of a positive test is only
6% . Performing electrophys io logic testing on all patients
.
regardless of ejection fraction, results in sustained ventricu-
lar tachycardia being induced in 10%% of tests and 20Sr of
patients with a positive lest experiencing a spontaneous
arrhythmic event within the next 12 months . Thesc results
suggest that optimal use of prognostic elect rophysiologic
testing is achieved by using an ejection fraction of <40°' as
a crude preselector of infarct survivors most needing such
testing
. When this strategy is used . only 30rr of infarct
survivors require electrophysiologic assessment . 2)1"£ of
patients tested will have inducible sustained ventricular
tachycardia and 28% of these will experience a spontaneous
arrhythmic event within the next I? months .
Discussion
Role of predischarge electrophysiologic testing
. Previous
studies from this hospital (8-10.14-16) and from other
centers )12
.20,21) have demonstrated that survivors of myo-
cardial infarction who are in stable condition can he stratified
II'lil Ill{ II'° . tit IMI V M Iris It ti RIAI IR, ; fill
cost	
v
briei,q
'_7
El' = ejcnion fe,a,on : EP - clci ~arhr .,ne, . l sit - I01 ., .mats ar
'„"i
o u
)s
9s
Vh
on the basis of an electrophysiologic study into a liar-
group at very Ion risk and a smaller croup at high risk of
espcricncine cenirieular tachyarrhythmias during follow-up .
This present study, based on an analysis of all patients who
undcr,cot elcctrophysio!ogic testing for prognostic reasons
after infarction at the Westmead Hospital over a 9-year
period
. reconfirms the original observations .
Qs excluding patients with uncontrolled ischcmia or heart
failure and those who had already experienced ventricular
tachycardia or fibrillation ,48 h after infarction, this surdv
evaluated :t group of patients who would normally he con-
sidered to be a low risk group . However . in h .2' i of these
patients, sustained monomorphic ventricular taehyeardia
was inducihle at electrophysiologic study, indicating the
prescnco of the underlying substrate for reentrant ventricu-
lar tachs arrhythmias . The clinical relei^ance of !his abnormal
result xvac estahlished during the Ist scar of follow-up by the
significantly higher incidence of spontaneous ventricular
arrhylhmias experienced by these latter patients compared
with the
remainder
who did not have inducible ventricular
tachycardia 119% v s . 2.9% :
p
< O.It(N15 : odds ratio
7
.2).
Furthermore during a mean follow-up period of 32
.
IS
months
. the incidence of a first arrhythmic event increased
to -Yi in those with inducihle ventricular tachycardia and
?7"i
of first arrhythmic events were fatal . Allowing for the
fact that oak witnessed instantaneous deaths and docu-
Table 7. Prediction of .Arrhythmic Events Occurring Within
IS lbnth, of Infarction C,ing Left Ventricular Ejection Eviction us :t
Preselcctor for Electrophysiotogic Testing Using Protocol''-: Influence of Licclion Fraction Selection threshold on Number Requiring
Programmed Stimulation and Overall Test Accuracy in 4231 Patients
'red,,,- Valua of I'redleoct Value of
Pu,ilrro Tc,t
	
Ncca c Ref Prohcuc
Result
Result Accurate
I'i1 Iril I41
98 96
9S 96
us
99 4'
97 95
99 95
41
Semri,rr, Sp ,h T ul, Io .
Eatmstimuli c
. ;,
I't
1 uw
2nd 13 9'
3rd 47 95
4rh .11. 9,
I
5th 49
Pushy'
LVEFQuallfier Ft Sad,
for EP Said, tof Popula{iaa Rcwll So I,
1 Sitl far FP Stud,
G'5
3h IS
as
24 45
<4a 311
M
<45 411
w
"5 n
Sot
All EF 7 1
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anted sustained ventricular tachyarrhythmias during
follow-up were accepted as end points predicted by electro-
physiologic t sting, the arrhythmic event rates quoted here
are best viewed as conservative estimates of the actual
incidence of reentrant arrhytlunias in the study period
. The
incidence of spontaneous arrhythmic episodes in the 1st year
of follow-up in the group with inducible ventricular tachy-
cardia in this series is similar to the risk of recurrence in
patients with late spontaneous sustained ventricular tachy-
cardia after infarction treated with antiarrhythmic drugs that
do not alter inducibility .
Why the need for electrophysiologic testing? The majority
of ventricular arrhythmias after infarction are reentrant in
nature (4-6) . They require an underlying potential circuit
and critically tined spontaneously occurring ventricular
ectopic heats to trigger them . Spontaneous ventricular ec-
topic activity, late QRS potential detection and depressed
left ventricular ejection fraction are common in patients in
the early months after infarction and are nonspecific guides
to the occurrence of serious arrhythnias . In a separate study
(9) at this hospital, the predictive value of electrophysiologic
study for spontaneous arrhythmic events was compared with
a variety of noninvasive tests in the same cohort of infarct
survivors . The noninvasive tests included detection of late
potentials on the signal-averaged ECG, ambulatory ECG
(Holter) monitoring, exercise testing, ejection fraction and
other clinical variables relating to the infarction, The induc-
tion of sustained monomorphic ventricular tachycardia, as
defined in this study, was associated with a 15-fold increase
in risk of arrhythmic events compared to a 3- to 5-fold
increase in risk for the best of the noninvasive tests . Multi-
variate analysis showed that no predictive model that ex-
cluded electrophysiologic testing achieved the predictive
accuracy of any combination that did include it . Further-
more, the predictive accuracy of ejection fraction combined
with electrophysiologic testing could not he significantly
improved by the addition of the results of any of the other
tests . In contrast to other variables such as ejection fraction,
Holler ECG monitoring or signal averaging, electrophysio-
logic testing identifies both the subgroup at risk and the
nature of the threat and therefore has the potential to guide
specific and appropriate prophylactic therapy (9) . It is pre-
cisely because a large proportion of first arrhythmic events-
37% in this series-are fatal and occur without warning in
otherwise low risk survivors of infarction that predictive
testing is so important . Sudden death in this context is
explained by the occurrence of rapid ventricular tachycar-
dia, which then dee_enerates to ventricular fibrillation (7) .
When programmed electrical stimulation is performed
during the phase of infarct healing, same patients are cate-
gorized as at high risk who are only transiently at such risk
and, conversely, some who are categorized as at low risk
may develop the reentrant substrate as the infarct scar
matures further. The risk of sudden death and ventricular
tachycardia is highest in the 1st weeks after infarction . Thus,
delaying electrophysiologic testing for several weeks after
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hospital discharge will expose patients to excess risk . If
electrophysiologic testing is to be used to test strategies to
prevent sudden death, it must be performed early (22). The
optimal timing of testing is as late as possible, butjust before
the usual time for hospital discharge after infarction .
Does it matter which electrophysiologic stimulation proto-
col is used? There is little consensus at present on what
constitutes the optimal stimulation protocol, even for those
with documented ventricular tachyarrhythmias (22 .23) . Pro-
tocols differ in their use of stimulation current (24), drive
cycle length (25) and number of extrastimuli and stimulation
sites (26,27) . Not surprisingly, therefore, there is even less
agreement on the best stimulation protocol to be used in
predicting future arrhythmic events in patients who have
never experienced a clinical arrhythmia before study
(13 .14 .28) . From the data presented here, it is apparent that
the stimulation protocol is critical to the overall value of
prognostic testing in infarct survivors. The ideal protocol
should be well tolerated by patients, easy to apply and yield
a sensitive and specific result that is applicable to individual
patients
. The two protocols used in this study have been
tested in large numbers of patients at this unit and meet some
of these criteria
. Stimulation protocol I is very similar to that
recommended by the North American Society for Pacing
and Electrophysiology for testing patients with documented
ventricular tachycardia and used by several investigators in
postinfarct testing (8,10,11,17) . With its sensitivity of only
21% to 25%, however, compared with that of 43% to 53% for
protocol 2, we consider protocol I to be of limited clinical
value and believe that protocol 2 is preferable and more
cost-effective . One of the main arguments against the use of
a greater number of extrastimuli is that such a protocol
increases the induction rate of clinically irrelevant arrhyth-
mias (29) . However, because only the induction of sustained
monomorphic ventricular tachycardia with a cycle length
?230 ms is of prognostic relevance, the induction of other
arrhythmias such as ventricular fibrillation should not be
considered an abnormal response . The induction of ventric-
ular fibrillation is safe and well tolerated by patients, pro-
vided they have been given adequate information on the
various events that may occur during the test .
A well organized electrophysiology laboratory and cum-
petent staff are essential prerequisites for the performance of
any provocative testing . We recommend, therefore, that
protocol 2 with a maximum of four extrastimuli be used for
routine electrophysiologic testing in infarct survivors until
an alternative protocol is hown to be superior after compa-
rable evaluation. Our current policy is to restrict pro-
grammed electrical stimulation to infarct survivors with a
left ventricular ejection fraction <40% and to use stimulation
protocol 2 . Clearly, the use of ejection fraction measured so
soon after acute infarction has many theoretic limitations
and the results may not correlate with subsequent measure-
ments after infarct expansion is complete (30,31) . Despite
this, the result is a useful, albeit crude, identifier of the group
cf infarct survivors most at risk of veatricular tachyarrhyth-
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mias and therefore most likely to benefit from electrophysi-
ologic testing .
Effect of drugs with antiarrhythmic actions on incidence of
spontaneous arrhythmic events
. Significantly more patients
with inducible ventricular tachycardia at electrophysiologic
testing were prescribed a beta-adrenergic blocking drug for
angina or hypertension control at some time during the
follow-up period. If the coincidental antiarrhythmic action of
such therapy had been beneficial. it might have :educed the
incidence of spontaneous arrhythmic events in these patients
and thereby biased the results of this study . Thus . the
removal of any such bias would only amplify the difference
already shown in the incidence of late spontaneous arrhyth-
mic events between infarct survivors with and without
inducible ventricular tachycardia .
In addition
. antiarrhythmic therapy was prescribed in an
attempt to provide protection from spontaneous arrhythmic
events in a prospective randomized controlled trial during 3
years of this data collection . At repeat electrophysiologic
testing, arrhythmia suppression was demonstrated in only 4
(22%) of the 18 patients who were randomized to receive
antiarrhythmic drug therapy . Furthermore, no benefit could
be demonstrated for patients wits inducible ventricular
tachyarrhythmias who were prescribed empiric antiarrhyth-
mic drug therapy to prevent spontaneous arrhythmic events
during follow-up (16). Therefore . the overall impact of
antiarrhythmic drug therapy on the results of this study was
probably negligible .
Prophylactic antiarrhythmic strategies for infarct survivors
with inducible ventricular tachycardia. For the majority of
infarct survivors. electrophysiologic testing confirms that
they have a negligible risk of experiencing spontaneous
reentrant ventricular tachyarrhythmias as a consequence of
their infarction . This allows for realistic informed reassur-
ance of the patient and is in itself a persuasive argument ror
offering routine electrophysiologic testing to infarct survi-
vors
. Fear of late sudden death is a major factor affecting
physical and psychologic rehabilitation among infarct survi-
vors .
For patients with inducible sustained ventricular lachy-
cardia,the risk of spontaneous arrhythmic events is appre-
ciable and justifies prophylactic intervention . Prevention or
amelioration of the first arrhythmic episode in the infarct
survivors with inducible ventricular tachycardia in this study
might have prevented death in seven patients
. The disap-
pointing lack of benefit of prophylactically prescribed anti-
arrhythmic drug therapy in randomized controlled trials of
infarct survivors with inducible ventricular lachyarrhylh-
mias is largely explained by the fact that drug therapy was
seldom able to suppress arrhythmia induction in these pa-
tients.
Only a relatively small number of patients have inducible
ventricular tachycardia after acute myocardial infarction . To
enable a randomized controlled trial to show a positive
result, a large multicenter trial of a very effective treatment
is required in patients predicted to be at high risk
. The
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automatic implantahle defibrillator is the only currently
available treatment with a high rate of eficacy fur pre enting
sudden arrhythmic death (32311 . The Australian Clinical
Trial of the Automatic Implantable Defibrillator IACT.AIDI
has heal designed to answer this question and rectuitinem is
ected to begin shortly .
Conclusion and clinical implications . Programmedelectri-
cal stimulation in survivors of uncomplicated myocardial
infarction provides a safe, well tolerated and accurate pre-
dictor of patients at risk of serious spontaneous reentrant
ventricular tachyarrhythmias during follow-up . Major differ-
ences exist in the prognostic abilities of various stimulation
protocols
. Protocol 2, using up to and including a fourth
extrastimulus . was the best of the stimulation protocols that
we have tested . In patients who have inducible sustained
ventricular tachycardia when this protocol is used, the
incidence of spontaneous ventricular tachyarrhythmias dur-
ing follow-up is 25%. and 37ck of first episodes are fatal. In
the majority (949r1 of infarct survivors, this protocol will be
unable to induce sustained
ventricular
tachycardia . This
normal test result has a very high specificity and can be used
to give patients strong reliable reassurance that they are at
negligible risk of sudden arrhythmic death . By combining
left ventricular ejection fraction and electrophysiologic test-
ing, infarct survivors at greatest risk can be identified in a
more cost-effective way . A radionuclide-measured left ven-
tricular ejection fraction <4Oc at the time of hospital
discharge identified the 33% of infarct survivors who most
needed electrophysiologictesting
. These improved methods
of detecting infarct survivors at high risk of late ventricular
tachvarrhythmias and sudden death make trials of effective
prophylactic antiarehythmic treatment possible .
Performance of electrophysiologic testing in infarct sur-
vivors fur evidence of ventricular electrical instability should
be feasible in the majority of hospitals with a bnsy coronary
care unit . Late arrhythmic death from a reentrant arrhythmia
during follow-up after myocardial infarction should be con-
sidered a failure of postinfarction management rather than an
unavoidable or untreatable chance occurrence . More effort
needs to he directed toward identifying and treating such
patients prophylactically .
We oimefully ackoowlcdgc the help of Anita Wall, Wcstmead Hespilal, in
the dma urllcann and fellow-up of
patients enmlled In In ., oody .
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